sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
ETON
Updated 10/6/2026, 2:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals, Inc. | Sale | $2,953,572 | MAIER PAUL V Director | 50,000 sh | at $59.07 | Filed Aug 31, 4:06 PM ET | Amended | Filing |
| ETON Eton Pharmaceuticals, Inc. | Sale | $2,953,572 | MAIER PAUL V Director | 50,000 sh | at $59.07 | Filed Aug 28, 4:51 PM ET | Filing | |
| ETON Eton Pharmaceuticals, Inc. | Sale | $1,626,750 | Krempa David Chief Business Officer | 25,000 sh | at $65.07 | Filed Aug 24, 5:19 PM ET | Filing | |
| ETON Eton Pharmaceuticals, Inc. | Sale | $6,087,773 | BRYNJELSEN SEAN President & CEO, Director | 100,000 sh | at $60.88 | Filed Aug 20, 6:26 PM ET | Filing | |
| ETON Eton Pharmaceuticals, Inc. | Sale | $1,063,033 | Opaleye Management Inc. 10% owner | 28,315 sh | at $37.54 | Filed Jul 17, 7:12 PM ET | Amended | Filing |
| ETON Eton Pharmaceuticals, Inc. | Sale | $1,063,033 | Opaleye Management Inc. 10% owner | 28,315 sh | at $37.54 | Filed Jul 16, 5:14 PM ET | Filing |